AssetMark’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
AssetMark's ORKA Position: Q3 2026 in Review
AssetMark opened a new position in Oruka Therapeutics (ORKA) in Q3 2026: 6 shares worth $500. The stake represents ﹤0.01% of the portfolio and ranks #3407 among its holdings.
175 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.
- AssetMark held 6 shares of Oruka Therapeutics worth $500 as of Q3 2026.
- Oruka Therapeutics was a new AssetMark position in Q3 2026.
- Oruka Therapeutics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3407 holding.
- 175 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.